Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial

Karim Fizazi, Pablo González Mella, Daniel Castellano, J.N. Minatta, Arash Rezazadeh Kalebasty, David R. Shaffer, Juan Carlos Vázquez Limón, Héctor Manuel Sánchez López, Andrew J. Armstrong, Lisa G. Horvath, Diogo Assed Bastos, Neha P. Amin, Jia Li, Keziban Ünsal-Kaçmaz, Margitta Retz, Fred Saad, Daniel P. Petrylak, Russell K. Pachynski